Neurogen (NRGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurogen (NRGN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (333)	10/9/2002 8:11:14 PM
From: mopgcw	Read Replies (1) of 523

Neurogen Sees 4th Quarter Charge Up To $500,000 On Workforce Cuts Wednesday October 9, 5:09 pm ET WASHINGTON -(Dow Jones)- Neurogen Corp. (NasdaqNM:NRGN - News) expects to take a charge of not more than $500,000 in the fourth quarter related to workforce cuts it had announced earlier this month. Neurogen eliminated 24 jobs, or about 10% of its staff, in a reorganization of departments. The drug development company said the job cuts were needed to improve efficiency of its drug discovery platform, cut costs and align resources with long-term goals. Neurogen is a drug discovery company based in Branford, Conn.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next